Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Melanoma 32Hodgkin Disease 29Lymphoma 10Sarcoma 7Uveal Melanoma 5Neoplasm Metastasis 4Neoplasms 3Leiomyosarcoma 2HIV Infections 2Solitary Fibrous Tumors 1Solid Tumor 1Skin Neoplasms 1Sarcoma, Synovial 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Neuroblastoma 1Lymphoma, T-Cell, Peripheral 1Immunotherapy 1Hyperthermia 1Hematologic Diseases 1Carcinoma 1Advanced Melanoma 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Doxorubicin 5brostallicin 2Sorafenib 2Radiation Dose Hypofractionation 2Nivolumab 2Ifosfamide 2Etoposide 2AZD 6244 2thymoglobulin 1tazemetostat 1sotigalimab 1selinexor 1romidepsin 1perifosine 1pembrolizumab 1pazopanib 1lorvotuzumab mertansine 1fludarabine phosphate 1exatecan 1decitabine and cedazuridine drug combination 1Trabectedin 1Thiotepa 1Temozolomide 1Tacrolimus 1Sunitinib 1Stem Cell Transplantation 1Specimen Handling 1Sirolimus 1Razoxane 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neurofibrosarcoma × Dacarbazine × Clear all
NCT00837148 2015-11-20

Sorafenib and Dacarbazine in Soft Tissue Sarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
37 enrolled 6 charts
Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡